Alere Analytics, an Alere subsidiary specializing in healthcare analytics and clinical decision support (CDS) technology, today announced the availability of its Electronic Laboratory Reporting (ELR) Solution to assist hospitals with submitting reportable lab results to State Departments of Health. Under Meaningful Use Stage 2, a new core objective requires that hospitals provide “ongoing successful submission of reportable lab results” to the State Departments of Public Health. As part of Alere Analytics’ Clinical Surveillance Solution, the ELR module can help eligible hospitals satisfy this requirement, while improving patient care quality and providing better coordination between lab personnel and clinicians.
“Our Company has been providing State Departments of Health with the necessary tools for statewide collection of reportable laboratory results for over a decade. Built on our extensive years of experience, our Electronic Laboratory Reporting (ELR) Solution was a natural product evolution of our core technology competencies,” said Mansoor Khan, Sc.D., Chief Executive Officer of Alere Analytics. “In addition to continuing to work with State Departments of Health, we are now pleased to directly offer hospital labs in all states our proven ELR technology as a low-cost, simple and effective way to satisfy Meaningful Use Stage 2, as well as provide a comprehensive solution to improve efficiency, patient safety, and outcomes while maximizing reimbursements.”
Delivered on the Alere Analytics platform using a cloud-based, SaaS environment, the ELR Solution captures all codes associated with diseases, conditions, lab tests and demographic data by leveraging industry messaging standards, such as HL7v2.X, and then delivers this information to the appropriate state authority. As a trusted technology partner, Alere Analytics is certified for Meaningful Use Stage 2 by the ONC-Authorized Testing and Certification Body for its Electronic Laboratory Reporting and Communication Portal. Alere Analytics’ ELR Solution, through which the State of Massachusetts has collected reportable lab results since 2004, is currently utilized by 98% of all hospitals in the state. The State of Iowa is also implementing the company’s ELR Solution to satisfy Meaningful Use requirements.